Despite over $66.8 billion invested globally in healthcare AI (2021 alone), the field has produced spectacular failures alongside its successes. Understanding what went wrong—and why—is essential for any hospital considering AI adoption.
China has emerged as the world's fastest-growing healthcare AI market, demonstrating that large-scale medical AI deployment is achievable through coordinated policy, infrastructure investment, and strategic regulatory frameworks. This article provides comprehensive analysis of China's medical AI ecosystem, examining market growth from $900 million in 2020 to a projected $18.9 billion by 2030, t...
The UK's NHS AI Lab, operating from 2019 to 2025 with £250 million in initial funding, represents the world's most ambitious national attempt to systematically deploy artificial intelligence in healthcare. This analysis examines the programme's comprehensive evaluation, documenting both its remarkable achievements—including £44 million in demonstrated cost savings and the development of crucial...
Ukraine's regulatory trajectory aligns with the EU Medical Device Regulation (MDR) through ongoing European integration reforms. Understanding the European CE marking process—with its emphasis on clinical evidence and post-market surveillance—directly informs how Ukrainian hospitals should evaluate AI diagnostic tools.
As Ukraine develops its regulatory framework for medical AI (aligned with EU MDR through recent reforms), understanding the world's largest medical AI market provides invaluable lessons. The US FDA has authorized over 1,200 AI/ML-enabled medical devices—more than any other regulatory body—making it the de facto testing ground for medical AI deployment.
For ScanLab and any medical AI initiative targeting Ukrainian healthcare, regulatory compliance isn't optional—it's existential. Understanding the regulatory landscape determines:
As Ukraine develops its regulatory framework for medical AI (aligned with EU MDR through recent reforms), understanding the world's largest medical AI market provides invaluable lessons. The US FDA has authorized over 1,200 AI/ML-enabled medical devices—more than any other regulatory body—making it the de facto testing ground for medical AI deployment.
Navigating the regulatory landscape for medical AI requires understanding three distinct frameworks: the FDA's mature Software as Medical Device (SaMD) pathway with over 1,200 approved AI/ML devices, the EU's dual MDR/AI Act compliance burden, and Ukraine's transitional system awaiting MDR harmonization. This analysis maps pathways for ScanLab and similar Ukrainian medical AI initiatives, ident...
This article examines the critical data quality standards required for medical imaging AI systems, revealing that of 1,016 FDA-approved AI medical devices, 93.3% did not report training data source and 76.3% lacked demographic information. We establish a comprehensive framework for data quality assessment including the six pillars of medical imaging data quality, bias sources and mitigation str...
Models pre-trained on a Collection of Public Medical Image Datasets (CPMID) covering X-ray, CT, and MRI outperformed ImageNet pre-training by: